Apollo Hospitals Q2: ₹5,545 Cr Revenue, ₹636 Cr Profit Growth

Apollo Hospitals Enterprise Limited has demonstrated strong performance in Q2 FY25, showcasing consistent growth across healthcare services, pharmacy distribution, and digital health segments. The quarter was marked by operational expansions, clinical achievements, and strategic initiatives reinforcing Apollo’s leadership in healthcare.

Apollo Hospital Q2 Quick Insights

• Revenue: ₹5,589.3 crore, up by 17.1% YoY.
• Net Profit: ₹395.7 crore, increased by 58% compared to last year.
• EPS: ₹26.34, up by 62.6% YoY.
• Segment Performance: The best-performing segment was Healthcare Services, with revenue of ₹2,920.4 crore, while Digital Health & Pharmacy distribution showed a strong YoY growth of 17% with revenues of ₹2,282.2 crore.
• Management's Take: "Strong growth driven by continued expansion in healthcare services and robust performance in pharmacy distribution. Outlook remains positive."
• Stock Reaction: Shares were up by 3% post-results, reflecting positive investor sentiment.

Apollo Hospital’s Management Commentary

"Apollo Hospitals has demonstrated strong growth this quarter, driven primarily by robust demand in both healthcare services and digital health initiatives. Our healthcare services segment, including new hospitals and existing facilities, contributed significantly to revenue growth. We continue to see a positive trend in patient volumes, reflecting the strength of our brand and our commitment to quality care. The pharmacy distribution and digital health segment also performed well, driven by expanded reach and customer trust in our digital platforms. As we move forward, we remain focused on sustainable growth and further strengthening our market position in both core healthcare and ancillary services. With ongoing investments in technology and infrastructure, we are confident about delivering consistent, long-term value to our stakeholders."

About Apollo Hospitals

Apollo reported a robust capital employed across its various segments, led by healthcare services with total assets of 127,657 million. The Digital Health and Pharmacy distribution segment also saw significant capital allocation, supporting the company’s digital expansion strategy. Apollo remains committed to investing in healthcare infrastructure with 10,702 million in capital employed for new hospital projects.

Conclusion

Apollo Hospitals’ Q2 FY25 results underscore its strong operational performance and expanding digital healthcare initiatives. By combining clinical excellence with strategic expansions in digital health and pharmacy, Apollo is well-positioned for sustained growth in the Indian healthcare market. The quarter’s performance, marked by steady revenue increases and profit margins, reflects Apollo’s leadership and adaptability in a rapidly evolving healthcare landscape. Apollo Hospitals' commitment to innovation, quality care, and digital integration signals a promising future as it continues to drive healthcare transformations in India.